ExodusPoint Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,005
Closed -$247K 2070
2023
Q3
$247K Buy
5,005
+3,880
+345% +$191K ﹤0.01% 1425
2023
Q2
$88K Buy
+1,125
New +$88K ﹤0.01% 1670
2021
Q4
Sell
-690
Closed -$398K 2618
2021
Q3
$398K Buy
690
+81
+13% +$46.7K 0.01% 1460
2021
Q2
$276K Buy
+609
New +$276K ﹤0.01% 1718